The DEA has forwarded a petition to change the federal regulatory classification for psilocybin, the psychedelic compound found in "magic mushrooms," to HHS for a medical and scientific review. The ...

The Trump administration is set to weigh in on whether the hallucinogenic compound psilocybin should be moved into a less restrictive class of drugs under federal regulations. Regulation of psilocybin ...

A hand in a blue glove plucks a white mushroom from a dense stand of mushrooms. Mature magic mushrooms are carefully harvested to minimize damage. Credit: Filament Health Some scientists theorize that ...

As psychedelic-assisted therapy grows in popularity, several substances are being recognized for their potential in treating trauma. Psilocybin, ketamine, and MDMA have emerged as some of the most ...

Wood-lover paralysis is a poorly understood syndrome related to consuming a native species of magic mushroom, with sufferers ...

In 2016 psychiatrist Benjamin Kelmendi was treating two patients with severe, treatment-resistant obsessive-compulsive disorder (OCD) at a Connecticut mental health center when the patients abruptly ...

The matchup: Two doses of psilocybin, the active ingredient in “magic mushrooms,” against a six-week course of the popular antidepressant escitalopram, often sold as Lexapro or Cipralex. Escitalopram ...

New Mexico’s Medical Psilocybin Act signals more than therapeutic access. It reflects a policy evolution, one where lawmakers, not just voters, are beginning to treat psychedelic medicine as a ...

Imagine a severely depressed woman—let’s call her Amber—who just arrived at her therapist’s office. She is curious about receiving her first dose of psilocybin in a Phase 3 clinical study. Psilocybin ...

A new study published in Nature Neuroscience provides a detailed look at how the psychedelic drug psilocybin facilitates the unlearning of fear in the brain. The research reveals that the drug does ...